These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 7821127)

  • 1. Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM.
    Jeppesen J; Zhou MY; Chen YD; Reaven GM
    Diabetes Care; 1994 Oct; 17(10):1093-9. PubMed ID: 7821127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why do low-fat high-carbohydrate diets accentuate postprandial lipemia in patients with NIDDM?
    Chen YD; Coulston AM; Zhou MY; Hollenbeck CB; Reaven GM
    Diabetes Care; 1995 Jan; 18(1):10-6. PubMed ID: 7698030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus.
    Chen YD; Swami S; Skowronski R; Coulston A; Reaven GM
    J Clin Endocrinol Metab; 1993 Jan; 76(1):172-7. PubMed ID: 8421086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glipizide treatment on postprandial lipaemia in patients with NIDDM.
    Jeppesen J; Zhou MY; Chen YD; Reaven GM
    Diabetologia; 1994 Aug; 37(8):781-7. PubMed ID: 7988780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
    Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
    Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
    Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM
    Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia.
    Jeppesen J; Hollenbeck CB; Zhou MY; Coulston AM; Jones C; Chen YD; Reaven GM
    Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):320-4. PubMed ID: 7749841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities.
    Lewis GF; O'Meara NM; Soltys PA; Blackman JD; Iverius PH; Pugh WL; Getz GS; Polonsky KS
    J Clin Endocrinol Metab; 1991 Apr; 72(4):934-44. PubMed ID: 2005221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control.
    Reaven GM; Johnston P; Hollenbeck CB; Skowronski R; Zhang JC; Goldfine ID; Chen YD
    J Clin Endocrinol Metab; 1992 May; 74(5):1020-6. PubMed ID: 1569149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of gemfibrozil treatment in sulfonylurea-treated patients with noninsulin-dependent diabetes mellitus.
    Shen DC; Fuh MM; Shieh SM; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1991 Sep; 73(3):503-10. PubMed ID: 1874929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease.
    Syvänne M; Hilden H; Taskinen MR
    J Lipid Res; 1994 Jan; 35(1):15-26. PubMed ID: 8138716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
    Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G
    Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial lipoprotein metabolism in normotriglyceridemic non-insulin-dependent diabetic patients: influence of apolipoprotein E polymorphism.
    Reznik Y; Pousse P; Herrou M; Morello R; Mahoudeau J; Drosdowsky MA; Fradin S
    Metabolism; 1996 Jan; 45(1):63-71. PubMed ID: 8544779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients.
    Wu MS; Johnston P; Sheu WH; Hollenbeck CB; Jeng CY; Goldfine ID; Chen YD; Reaven GM
    Diabetes Care; 1990 Jan; 13(1):1-8. PubMed ID: 2404714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus.
    Abbasi F; Chu JW; McLaughlin T; Lamendola C; Leary ET; Reaven GM
    Metabolism; 2004 Feb; 53(2):159-64. PubMed ID: 14767866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial lipid metabolism and beta-cell function in non-insulin-dependent (type 2) diabetes mellitus after a mixed meal with a high fat content.
    Cooper MB; Tan KC; Hales CN; Betteridge DJ
    Diabet Med; 1996 Sep; 13(9):816-27. PubMed ID: 8891457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin.
    Abbasi F; Carantoni M; Chen YD; Reaven GM
    Diabetes Care; 1998 Aug; 21(8):1301-5. PubMed ID: 9702437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-prandial metabolism of triglyceride-rich lipoproteins in non-insulin-dependent diabetic patients before and after bezafibrate treatment.
    Attia N; Durlach V; Roche D; Paul JL; Soni T; Zahouani A; Landron F; Labrousse F; Leutenegger M; Girard-Globa A
    Eur J Clin Invest; 1997 Jan; 27(1):55-63. PubMed ID: 9041378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glipizide treatment on response to an infused glucose load in patients with NIDDM.
    Sheu WH; Jeng CY; Fuh MM; Chen YD; Reaven GM
    Diabetes Care; 1995 Dec; 18(12):1582-7. PubMed ID: 8722055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.